Netherlands· NL-4600e66d6961
Tadalafil STADA 20 mg, filmomhulde tabletten
A tadalafil product containing tadalafil, registered in Netherlands by Stada Arzneimittel AG. The same ATC class is registered in 14 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Tadalafil is registered in 14 of 19 countries.
Countries holding a registration under ATC G04BE08 (tadalafil), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Tadalafil · ATC G04BE08
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of tadalafil costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $3.04 in Italy to $26.91 in United States — a ×8.9 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Tadalafil · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- US United States$26.91 (acquisition cost)
- CH Switzerland$4.37
- IT Italy$3.04
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- TADALAFIL
- Manufacturer
- Stada Arzneimittel AG
- Country
- Netherlands (NL)
- ATC code
- G04BE08
- ATC class
- Tadalafil
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id118511
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
315 interactions on record for tadalafil.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tadalafil · interactions on record
315 records
- 1 severe
- 96 moderate
- 12 minor
- 85 info
Most severe, free to view
- Amyl nitriteV03AB22severe
- ClotrimazoleA01AB18moderate
- CimetidineA02BA01moderate
- AprepitantA04AD12moderate
121 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under G04BE08
Tadalafil, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/db9ec260-e4e9-4a0a-af8b-3215efed2cda GET /v1/drugs/db9ec260-e4e9-4a0a-af8b-3215efed2cda?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h118511_smpc_en.pdf",
"strength": null,
"atc_label": "Tadalafil",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg118511",
"excipients": [
"CROSCARMELLOSE NATRIUM (E 468)",
"GLYCEROLTRIACETAAT (E 1518)",
"HYPROLOSE (E 463)",
"HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
"IJZEROXIDE GEEL (E 172)",
"LACTOSE 0-WATER",
"LACTOSE 1-WATER",
"MAGNESIUMSTEARAAT (E 470b)",
"NATRIUMLAURILSULFAAT",
"POLYSORBAAT 80 (E 433)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"TADALAFIL"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h118511_piluk.pdf",
"authorised_at": "2017/01/10",
"procedure_number": "NL/H/3650/004",
"dispensing_status": "Uitsluitend recept",
"registration_number": "118511",
"additional_monitoring": "N"
}See everything about tadalafil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.